Kwarlay.com

Navigating the News Maze with Clarity

Medicine

EMA Takes Break From X, Joins Bluesky

admin January 28, 2025

The government agency says X no longer suits its communication needs.

LEAVE A RESPONSE Cancel reply

admin

Medicine

Gen-Z Influence on Pharma M&A

admin March 14, 2024

Medicine

FDA Approves Arcutis Biotherapeutics’ Zoryve to Treat Patients with Mild to Moderate Atopic Dermatitis

admin July 10, 2024

Medicine

FDA Grants Fast Track, Breakthrough Designations to CG Oncology Inc’s Cretostimogene Grenadenorepvec

admin January 5, 2024

Medicine

Essential Pharma Acquires Reminyl, a Cholinesterase Inhibitor to Treat Mild to Moderately Severe Dementia from Janssen Pharmaceutica NV

admin April 20, 2024